scICB: A pan-cancer database of human temporal immune checkpoint blockade therapy at single-cell transcriptomic resolution

Fansen Ji; Weitong Bi; Jiawei Zhang; Bingjun Tang; Ying Xiao; Huan Li; Hao Liu; Boyang Wu; Fei Yu; Shizhong Yang; Gang Xu; Jiahong Dong

doi:10.1002/ctd2.70044

Clinical and Translational Discovery ›› 2025, Vol. 5 ›› Issue (3) : e70044 DOI: 10.1002/ctd2.70044

LETTER TO THE JOURNAL

scICB: A pan-cancer database of human temporal immune checkpoint blockade therapy at single-cell transcriptomic resolution

Author information +

History +

PDF

Cite this article

Download citation ▾

Fansen Ji, Weitong Bi, Jiawei Zhang, Bingjun Tang, Ying Xiao, Huan Li, Hao Liu, Boyang Wu, Fei Yu, Shizhong Yang, Gang Xu, Jiahong Dong. scICB: A pan-cancer database of human temporal immune checkpoint blockade therapy at single-cell transcriptomic resolution. Clinical and Translational Discovery, 2025, 5(3): e70044 DOI:10.1002/ctd2.70044

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Zhang L, Yu X, Zheng L, et al. Lineage tracking reveals dynamic relationships of T cells in colorectal cancer. Nature. 2018; 564(7735): 268-272.

[2]	Zeng Q, Mousa M, Nadukkandy AS, et al. Understanding tumour endothelial cell heterogeneity and function from single-cell omics. Nat Rev Cancer. 2023; 23: 544-564.

[3]	Hiam-Galvez KJ, Allen BM, Spitzer MH. Systemic immunity in cancer. Nature Reviews Cancer. 2021; 21(6): 345-359.

[4]	Waldman AD, Fritz JM, Lenardo MJ. A guide to cancer immunotherapy: from T cell basic science to clinical practice. Nat Rev Immunol. 2020; 20: 651-668.

[5]	Gao Y, Li J, Cheng W, et al. Cross-tissue human fibroblast atlas reveals myofibroblast subtypes with distinct roles in immune modulation. Cancer Cell. 2024; 42: 1764-1783.e10.

[6]	Fischer K, Voelkl S, Heymann J, et al. Isolation and characterization of human antigen-specific TCR alpha beta+ CD4(-)CD8- double-negative regulatory T cells. Blood. 2005; 105: 2828-2835.

[7]	Velikkakam T, Gollob KJ, Dutra WO. Double-negative T cells: setting the stage for disease control or progression. Immunology. 2022; 165: 371-385.

[8]	Gomes AQ, Martins DS, Silva-Santos B. Targeting γδ T lymphocytes for cancer immunotherapy: from novel mechanistic insight to clinical application. Cancer Res. 2010; 70: 10024-10027.

[9]	Yuen GJ, Demissie E, Pillai S. B lymphocytes and cancer: a love-hate relationship. Trends Cancer. 2016; 2: 747-757.

RIGHTS & PERMISSIONS

2025 The Author(s). Clinical and Translational Discovery published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.